multidrug-resistant tuberculosis
multidrug-resistant tuberculosis
Explore linked clinical trials. Standard reference: MONDO:000586123 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bioneer Q-RFIA Clinical Evaluation | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Recruiting | Not stated | 2026-09-23 | NCT05117788 | |
| Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 3 | 2026-09-16 | NCT07486024 | |
| Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, multidrug-resistant tuberculosis, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Phase 2 / Phase 3 | 2026-09-02 | NCT06441006 | |
| Training Protocol on the Natural History of Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, disease arising from reactivation of latent virus, extensively drug-resistant tuberculosis, gram-positive bacterial infections, latent tuberculosis infection, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Recruiting | Not stated | 2026-09-01 | NCT01212003 | |
| Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Active, not recruiting | Phase 2 | 2026-07-08 | NCT03828201 | |
| A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, rifampicin-resistant tuberculosis, tuberculosis | Not yet recruiting | Phase 3 | 2026-06-30 | NCT07675954 | |
| An Adaptive Randomized Controlled Trial | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, bacterial infectious disease, gram-positive bacterial infections, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, multidrug-resistant tuberculosis, mycobacterial infectious disease, sexually transmitted disease, tuberculosis, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-05-28 | NCT05633056 | |
| Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, tuberculosis | Recruiting | Phase 4 | 2026-05-13 | NCT07477119 | |
| Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Not yet recruiting | Not applicable | 2026-05-06 | NCT05007795 | |
| Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Recruiting | Not applicable | 2026-05-04 | NCT06590428 | |
| Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, rifampicin-resistant tuberculosis, tuberculosis | Not yet recruiting | Phase 2 | 2026-02-06 | NCT07393438 | |
| Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Genital Diseases, HIV Coinfection, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, bacterial infectious disease, gram-positive bacterial infections, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, multidrug-resistant tuberculosis, mycobacterial infectious disease, sexually transmitted disease, tuberculosis, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-01-26 | NCT05553236 | |
| Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, multidrug-resistant tuberculosis, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Not yet recruiting | Phase 3 | 2025-12-08 | NCT07268664 | |
| Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment | AIDS, Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, bacterial infectious disease, drug-resistant tuberculosis, gram-positive bacterial infections, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, multidrug-resistant tuberculosis, mycobacterial infectious disease, sexually transmitted disease, tuberculosis, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2025-10-20 | NCT05671718 | |
| Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, multidrug-resistant tuberculosis, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Active, not recruiting | Phase 3 | 2025-09-02 | NCT06649721 | |
| A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, multidrug-resistant tuberculosis, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Phase 3 | 2025-06-29 | NCT05824871 | |
| Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Active, not recruiting | Phase 3 | 2025-06-15 | NCT03568383 | |
| Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Sprains and Strains, Strains, bacterial infectious disease, gram-positive bacterial infections, injury, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Not yet recruiting | Not stated | 2025-06-12 | NCT07017803 | |
| Novel Triple-dose Tuberculosis Retreatment Regimen | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, multidrug-resistant tuberculosis, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Phase 3 | 2025-04-13 | NCT04260477 | |
| Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 3 | 2025-04-06 | NCT05081401 | |
| Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 2 | 2025-02-03 | NCT05534750 | |
| Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Not yet recruiting | Not stated | 2024-11-05 | NCT06674291 | |
| A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 4 | 2022-08-10 | NCT05493267 |